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dysmenorrhea and non-menstrual pain were the predominant symptom 
concepts. Other commonly reported symptoms were specific pelvic pain both 
during and between periods, deep dyspareunia, dyschezia, cramping, back pain, 
heavy bleeding and nausea. The most predominant impact concepts were 
difficulty performing both daily and work activities. Results support a 
preliminary conceptual model based on literature review and expert interviews. 
Draft instrument items were tested and refined through the CI process, and the 
draft EPDD was finalized for subsequent psychometric testing in preparation for 
use in clinical trials. CONCLUSIONS: The FDA PRO Guidance states that 
measures should be conceptually valid as they relate to the disease being 
studied, meet a threshold of psychometric soundness, and be relevant to 
patients. This research represents an important step toward establishing the 
EPDD as “fit for purpose” relative to the FDA PRO Guidance for use in support of 
label claims; and supports the development of a diary that better reflects the 
American Society for Reproductive Medicine’s recommendations for outcome 
measures in pain clinical trials.  
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RESPONSIVENESS OF THE FACE-Q: A NEW PRO FOR FACIAL AESTHETIC 
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Pusic A1, Scott A1, Klassen A2, Cano S3 
1Memorial Sloan-Kettering Cancer Center, New York, NY, USA, 2McMaster University, Hamilton, 
ON, Canada, 3ScaleReport, Stotfold, UK  
OBJECTIVES: The ability to detect clinically meaningful change from the 
patients’ perspective is critical to evaluating new techniques and technologies 
for facial aesthetic patients. The FACE-Q is a new patient-reported outcome 
(PRO) instrument composed of scales that measure outcomes for patients having 
any type of facial cosmetic surgery, procedure or facial injectable. The objective 
of our study was to determine the responsiveness of the FACE-Q scale entitled 
“Satisfaction with Facial Appearance”. METHODS: The Satisfaction with Facial 
Appearance scale is composed of 10 items that ask about satisfaction using 
descriptors (e.g., symmetry; proportion) as well as scenarios (e.g., in photos; 
bright lights). Data were collected from 489 patients in Canada and the USA 
between June 2010-2012 (response rate 78%). Responsiveness was examined in 97 
facelift patients by comparing pre and post- treatment Rasch transformed scores 
(range 0-100) using paired t-tests and calculating Kazis’ effect size and the 
standardized response mean. In addition, a change score for each patient was 
computed and categorized into 5 groups depending on the size and direction of 
their change score. RESULTS: Participants ranged in age from 37-77 years; 10 
were male, 86 female. FACE-Q scores were significantly higher following a 
facelift (mean, SD; pre 45,16 vs. post 56, 21 respectively, p<0.0001). These scores 
were associated with ‘moderate’ effect sizes (ES = 0.68, SRM = 0.50). Preliminary 
MID analyses suggested an 8 point difference in total scores. This difference was 
exceeded in our analysis (mean change, SD = 11, 22). For individual-level 
findings, 94 out of 97 face-lift patients reported significant improvement in 
satisfaction with facial appearance. CONCLUSIONS: The FACE-Q scale 
‘Satisfaction with Facial Appearance’ is capable of detecting clinically important 
change in facelift patients. Further responsiveness research is now needed with 
other facial aesthetics patient groups to add to the evidence base for the use of 
this scale.  
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UNDERSTANDING DIFFERENCES AMONG ERECTILE DYSFUNCTION PATIENTS 
GLOBALLY  
Chapnick J1, Gross HJ1, Pomerantz D1, Mould J2 
1Kantar Health, Princeton, NJ, USA, 2Pfizer, New York, NY, USA  
OBJECTIVES: Erectile dysfunction (ED) is a common sexual problem in  
men, although under-reporting of ED is widespread. This analysis seeks to 
explore the prevalence of the condition across select geographies and to 
compare the profile of sufferers among men identifying with an ED problem. 
METHODS: Data from 94,711 men interviewed in the US, EU (UK, France, 
Germany, Italy, Spain), Japan (JP), China (CH), Brazil (BR), and Russia (RU) 
National Health and Wellness Surveys, a cross-sectional Internet or CAWI-based 
survey representative of the adult population, conducted in 2011 or 2012. Data 
were weighted based on sex and age for each region. Men were classified as 
having ED if in the past six months, they had difficulty achieving/maintaining an 
erection. Health-related quality of life (HRQoL) was assessed with the SF-12v2, 
and activity impairment was measured with the Work Productivity and Activity 
Impairment questionnaire (WPAI). Comparisons between patient groups were 
made with chi-square tests for categorical variables and ANOVA for continuous 
variables. RESULTS: Prevalence of ED differs significantly across geographies, 
with Japan having the highest percentage (42.6%, 21.7 M) followed by China 
(34.7%, 87.8 M) and US (33.7%, 37.6 M), and Brazil having the lowest (14.9%, 10.0 
M) (p<0.05). In the established markets (US, EU, Japan) ED sufferers are 
significantly older (mean ages 51, 57 and 52, respectively) than in emerging 
markets (CH, BR, RU) (mean ages 45, 44 and 46) (p<0.05). Men with ED in Russia 
had significantly lower PCS (45.5) and MCS (42.3) QoL scores compared to all 
other regions (p<0.05). Men with ED in China reported the greatest degree of 
work productivity loss (34% vs. ~20–25%, p<0.05) and activity impairment (32% 
vs. 19–30%, p<0.05). CONCLUSIONS: Cross-regional comparisons of Erectile 
Dysfunction can provide insights to the magnitude of the problem and assess 
disease burden among these sufferers.  
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IMPACT OF ABORTION COMPLICATIONS ON HEALTH-RELATED QUALITY OF 
LIFE IN UGANDA  
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University of Washington, Seattle, WA, USA  
OBJECTIVES: Annually, there are 297,000 mostly illegally-induced abortions 
leading to at least 85,000 complications in Uganda. While the impact of abortion 
complications on clinical outcomes and health care costs has been reported, we 
found no reports on health-related quality-of-life (HRQol). In this study, we 
report an assessment of the impact of abortion complications on HRQol using 
the EQ-5D questionnaire. METHODS: We interviewed women discharged after 
treatment for abortion complications and women visiting a regional referral 
hospital for routine obstetric care. We administered the EQ-5D and collected 
demographic, socioeconomic, and social support data using the social support 
questionnaire short-form. We performed descriptive analyses using t-tests and 
chi-square tests, and multiple linear regression to examine the association 
between abortion complications and EQ-5D Scores. RESULTS: Our study included 
139 women (70 with abortion complications, and 69 receiving routine obstetric 
care). A larger proportion with abortion complications than receiving routine 
obstetric care reported some or severe problems in all 5 domains of the EQ-5D 
(Mobility: 23% v 13%, p=0.126; Self-care: 42% v 24%, p=0.033; Usual Activities: 49% 
v 16%, p<0.001; Pain/Discomfort: 68% v 25%, p<0.001; and Anxiety/Depression: 
60% v 22%, p<0.001). Women with abortion complications had a lower mean 
visual analogue scale score (60 v 68, p<0.001). After adjusting for age, marital 
status, number of children alive, social support score and employment status, 
women with abortion complications had a lower mean EQ-5D index score than 
those receiving routine obstetric care (unadjusted difference = 0.12, 95% CI: 0.08-
0.17, p<0.001; adjusted difference = 0.11, 95% CI: 0.06-0.17, p<0.001). 
CONCLUSIONS: Our study suggests that abortion complications are associated 
with diminished health-related quality of life. In addition to economic and 
clinical consequences, complications resulting from induced, often unsafe, 




THE EFFECT OF DIFFERENT TYPES OF HYSTERECTOMY ON FEMALE SEXUAL 
FUNCTION AND QUALITY OF LIFE  
Hock M1, Tóth S2, Hartmann G1, Hajnal B1, Kránicz J1, Boncz I1, Bódis J1,  
Koppán M1 
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OBJECTIVES: To follow up changes in sexual function and quality of life after 
hysterectomy, particularly regard to different surgical methods of hysterectomy, 
and to review the incidence of incontinence during the post-operative period. 
METHODS: A total number of 200 hyserectomised women were asked to fill up 
the questionnaire, 164 of them were willing to help us by answering it. Twenty 
one women were excluded from the study because of depression, resulted in 143 
processed questionnaires. Patients were randomized by snowball method. Three 
questionnaires were used for data collection: own-created public/general 
questionnaire, the SF 36 questionnaire, and a shortened version of two 
questionnaires to evaluate sexual function (Female Sexual Function Index and 
Lemack). For the statistical analysis t-test or Mann-Whiney U-test was used. The 
statistical analysis was performed by using SPSS 17.0 system. Chi square test 
was used to review categorical variables. The significance level of p ≤ 0.05 was 
used. RESULTS: There was no statistically significant difference in quality of life 
between the preformed subgroups. Reviewing the sexual function in the four 
different surgery methods, there was no statistically significant difference 
between the average scores. Further rewieving of the average scores of the 
subgroups showed statistically significant differences (p = 0.047). In the subgroup 
of vaginal hysterectomised women, there was a significantly higher incidence of 
women, who felt pain once in a while during sexual intercourse and also was a 
significantly higher incidence (p = 0.023) of women, who had urinary 
incontinence. CONCLUSIONS: Based on our results, total vaginal hysterectomy 
did not significantly affect the quality of life, but it can affect sexual function and 
to increase the risk of developing incontinence.  
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ARE QUALITY IMPROVEMENTS SUSTAINED? LONG-TERM EFFECTIVENESS  
OF A PHYSICIAN-FOCUSED INTERVENTION TO REDUCE POTENTIALLY 
INAPPROPRIATE MEDICATION PRESCRIBING IN THE ELDERLY IN ITALY  
Lopatto J1, Keith SW1, Templin M1, Maio V1, Del Canale S2 
1Thomas Jefferson University, Philadelphia, PA, USA, 2Local Health Authority Parma, Parma, 
Italy  
OBJECTIVES: We successfully implemented a multi-factorial intervention 
targeting general practitioners (GPs) in the Parma Local Health Authority (LHA), 
Italy, to decrease inappropriate prescribing in the elderly. It remains unclear as 
to whether the improvement was long-lasting. We sought to determine whether 
reduction in exposure to potentially inappropriate medications (PIM) in the older 
population (≥65 years) continued after discontinuation of intervention, and, if so, 
what factors contributed to effectiveness. METHODS: Data on all outpatient 
pharmacy claims for the pre-intervention (2005 Q1-2007 Q3), intervention (2007 
Q4-2009 Q4), and post-intervention (2010 Q1-Q4) were retrieved. We assessed 
changes in quarterly incidence rates of PIM exposure for the intervention and 
post-intervention in both all PIM users and newly exposed users. Generalized 
estimating equations were used to model the odds of PIM exposure. RESULTS: A 
total of 299 GPs (98.7%) in the Parma LHA serving 111,282 older patients were 
included in this study. PIM exposure incidence rates declined for all users from 
7.1% prior to the intervention to 4.9% at the end of the intervention and 
continued to decline to 4.3% at the end of the post-intervention. Adjusted 
models attributed the intervention with an immediate reduction (p<0.001) and a 
steady decline in the odds of PIM exposure (p<0.001). No measured patient and 
GP characteristics modified the effect of the intervention. Results among newly 
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exposed users were similar to results for all users. CONCLUSIONS: Inappropriate 
prescribing in the elderly contributes to negative clinical and economic 
outcomes. Specific interventions have been utilized to decrease incidence of 
inappropriate prescribing, but there is little evidence on the long-term 
sustainability of such project effects. The significant reductions in PIM exposure 
after our intervention appear to have continued after its discontinuation, 
supporting the idea that the intervention concretely impacted GPs’ prescribing 




AGE-BASED OUTPATIENT ANTIBIOTIC PRESCRIBING IN THE UNITED STATES 
FROM 2000 TO 2010  
Lee GC1, Daniels K1, Lawson KA2, Attridge RT3, Lewis J1, Frei CR1 
1The University of Texas at Austin and The University of Texas Health Science Center at San 
Antonio, San Antonio, TX, USA, 2The University of Texas at Austin, Austin, TX, USA, 3University 
of the Incarnate Word, San Antonio, TX, USA  
OBJECTIVES: During the 1990s, U.S. outpatient antibiotic utilization declined 
after the launch of national educational campaigns; however, it is unknown if 
these trends were sustained in the last decade. The purpose of this study was to 
describe U.S. antibiotic prescribing trends from 2000 to 2010. METHODS: This 
was a retrospective analysis of nationally representative data from the Medical 
Expenditure Panel Survey (MEPS) from 2000 to 2010. Trends in population-based 
prescribing were examined for overall antibiotics and for non-otitis media (non-
OM) respiratory tract infections (RTIs) [bronchitis, pharyngitis, sinusitis, and 
upper-RTIs as defined by ICD-9-CM codes 460-463, 465, 466, 473, and 490]. Rates 
were reported for three age groups: children and adolescents (younger than 18 
years), adults (18-64 years), and older adults (≥65 years). Antibiotic prescriptions 
were identified using the Lexicon Multum classification system. Population 
estimates were obtained from the U.S. Census Bureau, and annual rates were 
reported per 1,000 persons. RESULTS: The overall annual rate of antibiotic 
prescriptions decreased from 377 per 1000 persons in 2000 to 365 per 1,000 
persons in 2010. Among children and adolescents, the overall and non-OM RTI 
antibiotic prescribing rates decreased by 19% and 12%, respectively. Both rates 
remained stable in adults. In contrast, the overall and non-OM RTI antibiotic 
prescribing rates increased by 16% and 7%, respectively, in older adults. This 
increase was attributed to a 30% increase in the use of fluoroquinolones and 
second-generation macrolides over the study period. CONCLUSIONS: Overall, 
antibiotic prescribing has decreased in the U.S. population over the last decade. 
This decrease has mostly occurred in children and adolescents while older 
adults have actually experienced an increase in antibiotic prescribing. Focused 
public policy initiatives are needed to promote the judicious use of antibiotics in 
older adults.  
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INEQUALITIES OF THE INFANT MORTALITY RATE AND POVERTY IN  
COLOMBIA  
Alvis-Zakzuk N1, Paternina-Caicedo A1, Carrasquilla-Sotomayor M1,  
De la Hoz-Restrepo F2, Alvis N3 
1Universidad de Cartagena, Cartagena de Indias, Colombia, 2Universidad Nacional de  
Colombia, Bogota, Colombia, 3Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, 
Colombia  
OBJECTIVES: The relationship between inequities in socioeconomic factors (i.e. 
poverty) and adverse health outcomes has being studied before, but most studies 
were aggregated by country. A further disaggregation may contribute to causality 
and may help explain the within country differences and lack of improvements 
of some health indexes. In order to assess inequalities in Colombia this study 
evaluate by geographical region (state) of the infant mortality rate in Colombia in 
1993 and 2005, the two years where the census took place. METHODS: This 
ecological study measures regional inequalities in the infant mortality rate (IMR), 
using these indexes: Rate difference (RD), incidence rate ratio (IRR) and 
population attributable risk (PAR). Poverty was measured as the index of 
unsatisfied needs (Necesidades Básicas Insatisfechas, NBI). A linear regression 
was made for the association between IMR and NBI (poverty), and beta-
coefficients with 95% confidence intervals (95%CI) were estimated. RESULTS: In 
1993, the absolute difference between regions (states) with more and less poverty 
(Chocó: 80.4%; Bogotá, D.C.:17.3%) was 63.1%. In 2005, this difference was 70.4%. 
For these years, the IRR of IMR between those (Choco and Bogota) states was 2.9 
y 4.2 and RD 56.4 y 59.2, respectively. The R-square between poverty and IMR 
was in 2005 63.8%, versus a R-square of 34.2% for 1993. The beta-coefficient of 
linear regression was 0.339 for 1993 (IC 95%, 0.167-0.552). For each perceptual 
point that decreases poverty in the states, a reduction of TMI by 0.339 for each 
1,000 live births. In 2005, this reduction was 0.646 for each 1,000 live births (IC 
95%, 0.468-0.823). CONCLUSIONS: Although Colombia has a trend of TMI 
reduction, health inequalities persist between states in the country. These 
inequalities increased between 1993 and 2005.  
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PREVALANCE OF INAPPROPRIATE MEDICATION USE IN ELDERLY IN A 
COMMUNITY PHARMACY  
Yucel A, Clark PM, Ozbay L, Yucel E 
Yeditepe University, Istanbul, Turkey  
OBJECTIVES: An aging population translates into an increase in drug use, while 
medication management is challenged by the uniqueness of geriatric 
pharmacology. Our objective is to understand the most frequent IMUs dispensed 
from community pharmacies. METHODS: We used Beers’ 2002 Criteria 
(regardless of diagnoses and conditions) in our analysis. The prescription 
repository from a downtown community pharmacy (Yalova, Turkey) with  
a diverse socio-economic demographic profile was retrospectively monitored to 
identify IMU. The Social Security Institution (SGK)’s “Medula” database  
was utilized to identify patients to whom at least one prescription was dispensed 
in the month of October 2011. The patient records were tracked back to  
the period between September and November 2011 to analyze their prescriptions 
details. SGK-Medula prescriptions for 192 elderly patients (≥60 years-old)  
were identified (108 female and 84 male). RESULTS: From data analysis, 424 
cases of IMU were identified. Each patient was exposed on average to 2.2 IMUs. 
The majority (61.8%) of all IMU cases involved non steroidal anti-inflammatory 
drugs (NSAID). The average use of NSAID per patient was 1.36. There was  
no statistically significant difference between female and male NSAID IMU.  
The second most IMU was chlorpheniramine usage, with 9% of all IMU  
cases; again no statistically significant difference was found between females 
and males. The third most frequently observed IMU involved nitrofurantoin  
in males (13.1%), and hydroxyzine in females (10.2%). Regardless of gender, 
ferrous sulphate (4.0%) was ranked the third overall most recorded  
IMU. Stimulant laxatives, alprazolam, doxazosin, and ticlopidine were also 
among the frequently observed IMU cases in this study. CONCLUSIONS: 
Prescriptions for the elderly should be systematically evaluated to check for  
IMU. NSAIDs, chlorpheniramine, nitrofurantoin, hydroxyzine, and ferrous 
sulphate may be especially worrisome due to high prevalence of exposure to 
these agents.  
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IMPACT OF DOCTORS' RECOMMENDATIONS ON SEASONAL AND H1N1 FLU 
VACCINATIONS FOR MEDICAID/STATE CHILDREN'S HEALTH INSURANCE 
PROGRAM (SCHIP) CHILDREN DURING THE 2009 H1N1 FLU PANDEMIC  
Villacorta R 
University of Southern California, Los Angeles, CA, USA  
OBJECTIVES: Seasonal flu vaccine uptake rates among socioeconomically 
disadvantaged children have been documented, but not much is known about 
the relationship between doctor’s recommendation for seasonal and H1N1 flu 
vaccines. During the 2009-2010 flu season, persons had access to two separate 
influenza vaccines to prevent H1N1- and seasonal flu-related complications. The 
study explored the impact of doctor’s recommendations for seasonal and H1N1 
flu vaccines on Medicaid/State Children’s Health Insurance Program (SCHIP)-
covered children’s seasonal and H1N1 flu vaccination. The hypothesis to be 
tested was that a doctor’s recommendation increases vaccine uptake for both 
vaccines. The current study addressed different marginal effects estimates from 
the bivariate model identification to characterize this hypothesis. METHODS: 
This study used the Centers for Disease Control and Prevention National 2009 
H1N1 Flu Survey and focused on the nationally representative subsample of 1794 
Medicaid/SCHIP children between the ages of 6 months to 17 years old.  
A bivariate probit model was used to jointly estimate the effects of doctors’ 
recommendations on seasonal and H1N1 flu vaccination. The model controlled 
for age, race, gender, household income, census region, number of household 
children, and past sickness. RESULTS: The choice framework resulted in  
a significant estimation of rho=0.532 (p=0.000) suggesting a positive correlation 
between the outcomes of seasonal and H1N1 vaccination. The average marginal 
effect from the bivariate probit model estimated that Medicaid/SCHIP children 
receiving a doctor’s recommendation for both, seasonal, and H1N1 were 34.5% 
(p=0.000), 11.5% (p=0.000), 14.1% (p=0.000), respectively, more likely to acquire 
seasonal and H1N1 flu vaccinations versus a doctor’s recommendation  
for neither. CONCLUSIONS: The results suggest a doctor’s recommendation  
was influential for vaccine uptake for Medicaid/SCHIP covered children during 
the 2009-2010 flu season. The findings suggest doctor’s recommendation  




VARIATION IN THE USE OF INHALED RESPIRATORY MEDICATIONS FOR 
PRETERM INFANTS WITH BRONCHOPULMONARY DYSPLASIA  
Slaughter JL1, Stenger MR1, Jadcherla SR1, Reagan PB2 
1Nationwide Children's Hospital/The Ohio State University, Columbus, OH, USA, 2The Ohio State 
University, Columbus, OH, USA  
OBJECTIVES: To determine 1) between-hospital variation in bronchodilator (BD) 
and inhaled corticosteroid (ICS) use for preterm infants with bronchopulmonary 
dysplasia (BPD) including hospital-specific treatment frequency, and 2) 
demographic and clinical variables associated with diuretic administration. 
METHODS: A retrospective cohort investigation was conducted using the 
Pediatric Health Information System (PHIS) database to determine between-
hospital variation in BD (Beta2-agonists; ipratroprium) and ICS utilization, as 
well as variables associated with their administration, among infants with 
evolving BPD at 28 days of age, born at 35 U.S. children's hospitals between 
January 2007-June 2011. Inclusion criteria: <29 weeks gestation, <1.5 kgs 
birthweight, survived 28 days, and on oxygen, CPAP, and/or ventilation for ≥28 
consecutive days. Between-hospital percent-use comparisons were limited to 
hospitals with >25 included infants to prevent overweighting of smaller-samples. 
RESULTS: During the 54-month study period, 1429 infants were identified with 
evolving BPD, of which 544 (38%) received bronchodilators (BDs) and 352 (25%) 
received ICS. Hospitals differed significantly in the use of BDs [intraclass 
correlation coefficient (ICC): 0.35] and ICS (ICC: 0.42) even after controlling for 
observed confounders with multilevel, multivariable logistic regression. By 
hospital (N=15), the percentage of patients that ever received these medications 
ranged from 5-81% (median:33; IQR:8%-56%) for BDs and from 0-60% (12; 2-35%) 
for ICS. At 3 hospitals (20%) no patients received ICS. Risk factors significantly 
associated with bronchodilator administration included: increasing length of 
mechanical ventilation, birth weight 500-749 grams (reference group: 1000-1499 
